Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards. KATIE THOMAS and CHARLES ORNSTEIN https://ift.tt/2xOKzCv https://ift.tt/2NNuQxE The New York Times Health Hospitals, Boards of Directors September 29, 2018 at 12:00AM